PXD069034-1

PXD069034 is an original dataset announced via ProteomeXchange.

Title	Surveying the proteome-wide landscape of Mitoxantrone and examining drug-sensitivity in BRCA1-deficient ovarian cancer using quantitative proteomics
Description	Mitoxantrone (MX) is regularly used to treat several cancers, yet despite its long history in the clinic, recent studies continue to unveil novel protein targets that may contribute to the cytotoxic effects of the drug, as well as potential non-canonical antitumor activity. A better understanding of MX’s cellular targets is required to fully comprehend the molecular consequences of treatment and to interpret MX-sensitivity in homologous recombination (HR)-deficient cancer. Here, we describe two approaches used to evaluate MX-activity in HR-deficient UWB1.289 ovarian cancer cells and survey the binding profile of MX using TMT-labeled quantitative proteomics and chemoproteomics. Mass spectrometry (MS) analysis of cellular extracts from MX-treated BRCA1- UWB1.289 cells revealed a unique downregulation of pathways instrumental to maintaining genomic stability, including single-strand annealing. Moreover, the BRCA1- cells exhibited a significant upregulation of proteins involved in ribosome biogenesis and RNA processing. Additional MS analyses following affinity-purification using a biotinylated-mitoxantrone probe (MXP) corrobo-rated these findings, which showed considerable targeting of proteins involved in ge-nomic maintenance and RNA processing. Our results suggest that an interplay of both canonical and non-canonical MX-antitumor activity overwhelms the BRCA1- cells. Fur-thermore, this study aids in characterizing the target landscape of MX, ultimately providing insights into off-target effects and MX-action in HR-deficient cancer.
HostingRepository	PRIDE
AnnounceDate	2025-12-01
AnnouncementXML	Submission_2025-11-30_17:35:44.955.xml
DigitalObjectIdentifier	https://dx.doi.org/10.6019/PXD069034
ReviewLevel	Peer-reviewed dataset
DatasetOrigin	Original dataset
RepositorySupport	Supported dataset by repository
PrimarySubmitter	Nicholas Woods
SpeciesList	scientific name: Homo sapiens (Human); NCBI TaxID: NEWT:9606;
ModificationList	monohydroxylated residue; iodoacetamide derivatized residue
Instrument	Orbitrap Fusion

Revision	Datetime	Status	ChangeLog Entry
0	2025-10-01 08:33:22	ID requested
⏵ 1	2025-11-30 17:35:45	announced

Wallin S, Pandithar S, Singh S, Kumar S, Natarajan A, Borgstahl GEO, Woods N, Surveying the Proteome-Wide Landscape of Mitoxantrone and Examining Drug Sensitivity in BRCA1-Deficient Ovarian Cancer Using Quantitative Proteomics. Proteomes, 13(4):(2025) [pubmed]

10.3390/proteomes13040061;

10.6019/PXD069034;

submitter keyword: Human, mitoxantrone, ovarian cancer

Nicholas Woods
contact affiliation	Eppley Institute for Research in Cancer University of Nebraska Medical Center
contact email	nicholas.woods@unmc.edu
lab head
Nicholas Woods
contact affiliation	University of Nebraska Medical Center - Eppley Institute for Research in Cancer
contact email	nicholas.woods@unmc.edu
dataset submitter

Dataset FTP location NOTE: Most web browsers have now discontinued native support for FTP access within the browser window. But you can usually install another FTP app (we recommend FileZilla) and configure your browser to launch the external application when you click on this FTP link. Or otherwise, launch an app that supports FTP (like FileZilla) and use this address: ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/12/PXD069034

PRIDE project URI

• PRIDE
  1. PXD069034
     1. Label: PRIDE project
     2. Name: Surveying the proteome-wide landscape of Mitoxantrone and examining drug-sensitivity in BRCA1-deficient ovarian cancer using quantitative proteomics